var data={"title":"Digoxin immune Fab: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Digoxin immune Fab: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6031?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=digoxin-immune-fab-drug-information\" class=\"drug drug_general\">see &quot;Digoxin immune Fab: Drug information&quot;</a> and <a href=\"topic.htm?path=digoxin-immune-fab-patient-drug-information\" class=\"drug drug_patient\">see &quot;Digoxin immune Fab: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160237\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>DigiFab</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160238\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>DigiFab</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1057851\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antidote, Digoxin</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F12669226\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <span style=\"text-decoration: underline\">Digoxin toxicity</span>:</b> Preterm and term neonates: <b>Note:</b> Estimation of the dose is based on the body burden of digitalis. This may be calculated if the amount ingested is known or the post-distribution serum drug level is known (round the dose up to the nearest whole vial). If the amount ingested is unknown, general dosing guidelines should be used.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Acute ingestion/overdose of <span style=\"text-decoration: underline\">known</span> amount:</b> IV:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Step 1: <i>Calculate total body digoxin load (mg)</i>: If parenteral overdose of digoxin or from oral capsules, total body load of digoxin is equal to the dose administered. If oral digoxin ingestion/overdose from elixir or tablets, the total body load should be calculated based on the following equation:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Total body load (mg) = 0.8 x [amount (mg) digoxin tablets or elixir ingested]</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Step 2: <i>Calculate number of vials needed</i>: Each vial of digoxin immune Fab 40 mg will bind ~0.5 mg of <b>digoxin</b>.</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Digoxin Immune Fab Dose (vials) = Total body digoxin load (mg) / 0.5 mg/vial</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Based on steady-state serum <span style=\"text-decoration: underline\">digoxin</span> concentration:</b> IV: <i>Dose may be determined by estimation with the following table or calculated based on the following equation: </i></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Digoxin Immune Fab Dose (mg) = [(serum digoxin concentration [ng/mL] x weight [kg]) / 100] x 40 mg/vial</p>\n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Dose Estimates of Digoxin Immune Fab (in mg) From Serum Digoxin Concentration</caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"middle\">\n        <tr>\n          <th rowspan=\"2\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Patient Weight</p>\n            <p style=\"text-indent:0em;\">(kg)</p></th>\n          <th colspan=\"7\" align=\"center\">\n            <p style=\"text-indent:0em;\">Serum Digoxin Concentration (ng/mL)</p></th></tr>\n        <tr>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">1 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">2 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">4 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">8 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">12 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">16 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">20 ng/mL</p></th></tr></thead>\n      <tfoot valign=\"top\">\n        <tr>\n          <td colspan=\"8\" align=\"left\">\n            <p style=\"text-indent:0em;\">\n              <sup>A</sup>Dilution of reconstituted vial to 1 mg/mL may be desirable.</p></td></tr></tfoot>\n      <tbody valign=\"middle\">\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">1</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">0.4 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">1 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">1.5 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">3 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">5 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">6.5 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">3</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">1 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">2.5 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">5 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">10 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">14 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">19 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">24 mg</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">5</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">2 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">4 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">16 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">24 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">32 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">40 mg</p></td></tr></tbody></table>\n    \n    <p style=\"text-indent:0em;\">\n      <b>Dosing adjustment in renal impairment:</b> There are no neonatal specific recommendations provided; use with caution; elimination of Fab-digoxin fragments may be prolonged with renal impairment; patients should have serum digoxin levels monitored closely (including unbound if possible) to identify/prevent recurrence of toxicity and to determine an appropriate time for re-digitalization (if applicable).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1057846\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=digoxin-immune-fab-drug-information\" class=\"drug drug_general\">see &quot;Digoxin immune Fab: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">Pediatric: <span style=\"text-decoration: underline\"><b>Digoxin toxicity</b></span>: Infants, Children, and Adolescents: <b>Note:</b> Estimation of the dose is based on the body burden of digitalis. This may be calculated if the amount ingested is known or the post-distribution serum drug concentration is known (round the dose up to the nearest whole vial). If the amount ingested is unknown, general dosing guidelines should be used.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acute ingestion of <span style=\"text-decoration: underline\">unknown</span> amount:</b> IV: Initial: 10 vials; if needed, may administer a second dose of 10 vials (to avoid a febrile reaction); a total dose of 20 vials is adequate to treat most life-threatening ingestions. In small children (&lt;20 kg), it is important to monitor for fluid overload.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acute ingestion of <span style=\"text-decoration: underline\">known</span> amount:</b> IV:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Step 1: <i>Calculate total body load (mg): </i>If parenteral overdose of digoxin or from ingestion or oral capsules, total body load of digoxin is equal to the dose administered. If oral digoxin ingestion/overdose from elixir or tablets, the total body load should be calculated based on the following equation:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Total body load (mg) = 0.8 x [amount (mg) digoxin tablets or elixir ingested]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Step 2: <i>Calculate number of vials needed: </i>Each vial of digoxin immune Fab 40 mg will bind ~0.5 mg of digoxin.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Digoxin Immune Fab Dose (vials) = Total digoxin body load (mg) / 0.5 mg/vial</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Based on steady-state serum digoxin concentration: IV: </b>\n      <i>Dose may be determined by estimation with the following tables or calculated based on the following equations for either mg dose or number of vials needed (use precaution to ensure appropriate equation):</i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Note:</b> Infants and Children &le;20 kg may require smaller doses; calculate the dose in milligrams (mg)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Digoxin Immune Fab Dose (<b>mg</b>) = [(serum digoxin concentration [ng/mL] x weight [kg]) / 100] x 40 mg/vial</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Digoxin Immune Fab Dose (<b>vials</b>) = (serum digoxin concentration [ng/mL] x weight [kg]) / 100</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">The following tables give an estimation of the amount of Digoxin Immune Fab needed based on the steady-state serum digoxin concentration.</p>\n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Infants and Children &lt;20 kg: Dose Estimates of Digoxin Immune Fab (in mg) From Serum Digoxin Concentration</caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"middle\">\n        <tr>\n          <th rowspan=\"2\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Patient Weight</p>\n            <p style=\"text-indent:0em;\">(kg)</p></th>\n          <th colspan=\"7\" align=\"center\">\n            <p style=\"text-indent:0em;\">Serum Digoxin Concentration (ng/mL)</p></th></tr>\n        <tr>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">1 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">2 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">4 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">8 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">12 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">16 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">20 ng/mL</p></th></tr></thead>\n      <tfoot valign=\"top\">\n        <tr>\n          <td colspan=\"8\" align=\"left\">\n            <p style=\"text-indent:0em;\">\n              <sup>A</sup>Dilution of reconstituted vial to 1 mg/mL may be desirable.</p></td></tr></tfoot>\n      <tbody valign=\"middle\">\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">3</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">1 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">2.5 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">5 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">10 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">14 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">19 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">24 mg</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">5</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">2 mg<sup>A</sup></p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">4 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">16 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">24 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">32 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">40 mg</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">10</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">4 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">16 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">32 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">48 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">64 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">80 mg</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">20</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">16 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">32 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">64 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">96 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">128 mg</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">160 mg</p></td></tr></tbody></table>\n    \n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Children and Adolescents &ge;40 kg: Dose Estimate of Digoxin Immune Fab (in # of Vials) From Serum Digoxin Concentration</caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"middle\">\n        <tr>\n          <th rowspan=\"2\" align=\"center\">\n            <p style=\"text-indent:0em;\">Patient Weight (kg)</p></th>\n          <th colspan=\"7\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Serum Digoxin Concentration (ng/mL)</p></th></tr>\n        <tr>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">1 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">2 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">4 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">8 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">12 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">16 ng/mL</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">20 ng/mL</p></th></tr></thead>\n      <tbody valign=\"top\">\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">40</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">0.5 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">5 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">7 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">60</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">0.5 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">5 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">7 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">10 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">70</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">6 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">9 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">11 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">14 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">80</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">7 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">10 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">13 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">100</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">20 vials</p></td></tr></tbody></table>\n    \n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Chronic toxicity (serum digoxin concentration unavailable):</b> IV:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants and Children &le;20 kg: 1 vial is adequate to reverse most cases of toxicity</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &gt;20 kg and Adolescents: 6 vials is adequate to reverse most cases of toxicity</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b> All patients: There are no pediatric specific recommendations provided; use with caution; elimination of Fab-digoxin fragments may be prolonged with renal impairment; patients should have serum digoxin levels monitored closely (including unbound if possible) to identify/prevent recurrence of toxicity and to determine an appropriate time for re-digitalization (if applicable).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160219\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution Reconstituted, Intravenous [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">DigiFab: 40 mg (1 ea)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160203\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1057855\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Parenteral: IV: Administration by IV infusion over at least 30 minutes is preferable. May also be administered by bolus injection if cardiac arrest is imminent (infusion-related reaction may occur). If an infusion-related reaction occurs, discontinue the infusion and reinitiate at a slower rate.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160232\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store vials at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze. Reconstituted solutions are stable for 4 hours when stored at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F). The following stability information has also been reported: May be stored at room temperature for up to 30 days (Cohen, 2007).  </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1057854\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Treatment of potentially life-threatening digoxin intoxication in carefully selected patients (FDA approved in pediatric patients [age not specified] and adults):</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Acute digoxin ingestion (ie, &gt;10 mg in adults; &gt;0.1 mg/kg or &gt;4 mg in children; ingestions resulting in steady-state serum concentrations &ge;10 ng/mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Chronic ingestions leading to steady-state digoxin concentrations &gt;6 ng/mL in adults or &gt;4 ng/mL in children</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Manifestations of life-threatening digoxin toxicity (eg, severe ventricular arrhythmias, progressive bradycardia, second- or third-degree heart block not responsive to atropine, serum potassium &gt;5.5 mEq/L in adults or &gt;6 mEq/L in children in presence of rapidly progressive signs of digoxin toxicity)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160260\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cardiovascular: Orthostatic hypotension, phlebitis, ventricular tachycardia (patients with atrial fibrillation; due to digoxin withdrawal), worsening of heart failure (due to digoxin withdrawal)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Endocrine &amp; metabolic: Hypokalemia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Hypersensitivity: Hypersensitivity reaction, serum sickness</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160225\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">There are no contraindications listed in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160207\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypersensitivity reactions: Digoxin immune Fab is derived from ovine (sheep) Fab immunoglobulin fragments; hypersensitivity reactions (eg, anaphylactic or anaphylactoid reactions, delayed allergic reactions) are possible. Patients with allergies to sheep proteins and patients with prior exposure to ovine antibodies or ovine Fab may be at a higher risk for  anaphylactic reactions. In patients who develop an anaphylactic reaction, discontinue the infusion immediately and administer emergency care; balance the need for epinephrine against its potential risk in the setting of digitalis toxicity.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">Processed with papain and may cause hypersensitivity reactions in patients allergic to papaya, other papaya extracts, papain, chymopapain, or the pineapple-enzyme bromelain. There may also be cross allergenicity with dust mite and latex allergens.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">&bull; Potassium imbalance: Patients experiencing acute digitalis toxicity may present with significant hyperkalemia due to shifting of potassium into the extracellular space. Upon treatment with digoxin immune Fab, potassium shifts back into the intracellular space and may result in hypokalemia.  Monitor potassium closely, especially during the first few hours after administration; treat hypokalemia cautiously when clinically indicated.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Heart failure (HF): In patients chronically maintained on digoxin for HF, administration of digoxin immune Fab may result in exacerbation of HF symptoms due to a reduction in digoxin serum concentration. If reinitiation is required, consider postponing until Fab fragments have been eliminated completely; elimination may take several days or longer, especially in patients with renal impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Renal impairment: Use with caution in patients with renal failure (experience limited); the Fab-digoxin complex will be eliminated more slowly. Toxicity may recur; prolonged monitoring for recurrence of symptoms and evaluation of free (unbound) digoxin concentrations (if test available) may be warranted in this patient population.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299196\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6219862\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=13231&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160215\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160227\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. In general, medications used as antidotes should take into consideration the health and prognosis of the mother; antidotes should be administered to pregnant women if there is a clear indication for use and should not be withheld because of fears of teratogenicity (Bailey, 2003).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1057850\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Prior to the first dose of digoxin immune Fab evaluate serum potassium, serum digoxin concentration, and serum creatinine; closely monitor serum potassium (eg, hourly for 4 to 6 hours; at least daily thereafter), temperature, blood pressure, and electrocardiogram after administration. <b>Total serum digoxin concentrations will rise precipitously following administration of digoxin immune Fab due to the presence of the Fab-digoxin complex; because digoxin bound to Fab fragments is not physiologically active this rise has no clinical meaning</b>. Therefore, avoid monitoring total serum digoxin concentrations until the Fab fragments have been eliminated completely; this may be several days to weeks in patients with renal impairment (Ujhelyi 1995). Monitor for volume overload in infants and small children (&lt;20 kg). Monitor for signs and symptoms of a hypersensitivity reaction.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160206\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Digoxin immune antigen-binding fragments (Fab) are specific antibodies for the treatment of digitalis intoxication in carefully selected patients; binds with molecules of digoxin and is then excreted by the kidneys and removed from the body.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160224\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: IV: Digitalis toxicity: Improvement may be seen within 20 to 90 minutes (Betten, 2006)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: V<sub>d</sub>: 0.3 L/kg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: 15 to 20 hours; may be increased up to 10-fold in patient with renal impairment</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (concentrations declining within 5 to 7 days)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323111\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution (reconstituted)</b> (DigiFab Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40 mg (1): $4,057.20</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160228\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Digibind (GB);</li>\n      <li>Digifab (SG);</li>\n      <li>DigiFab (TW)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Bailey B, &quot;Are There Teratogenic Risks Associated With Antidotes Used in the Acute Management of Poisoned Pregnant Women?&quot; <i>Birth Defects Res A Clin Mol Teratol</i>, 2003, 67(2):133-40.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-pediatric-drug-information/abstract-text/12769509/pubmed\" target=\"_blank\" id=\"12769509\">12769509</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Betten DP, Vohra RB, Cook MD, et al. Antidote use in the critically ill poisoned patient. <i>J Intensive Care Med</i>. 2006;21(5):255-277.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-pediatric-drug-information/abstract-text/16946442/pubmed\" target=\"_blank\" id=\"16946442\">16946442</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cohen V, Jellinek SP, Teperikidis L, et al, &quot;Room-Temperature Storage of Medications Labeled for Refrigeration,&quot; <i>Am J Health Syst Pharm</i>, 2007, 64(16):1711-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-pediatric-drug-information/abstract-text/17687059/pubmed\" target=\"_blank\" id=\"17687059\">17687059</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    DigiFab (digoxin immune fab [ovine]) [prescribing information]. West Conshohocken, PA: January 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hickey AR, Wenger TL, Carpenter VP, et al, &ldquo;Digoxin Immune Fab Therapy in the Management of Digitalis Intoxication: Safety and Efficacy Results of an Observational Surveillance Study,&rdquo; <i>J Am Coll Cardiol</i>, 1991, 17(3):590-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-pediatric-drug-information/abstract-text/199377/pubmed\" target=\"_blank\" id=\"199377\">199377</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schneider PJ, McCollam PL, and Osborn JJ, &quot;Possible Dissociation of the Digibind-Digoxin Complex in Renal Failure,&quot; <i>DICP</i>, 1991, 25(11):1269.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-pediatric-drug-information/abstract-text/1763546/pubmed\" target=\"_blank\" id=\"1763546\">1763546</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ujhelyi MR and Robert S, &quot;Pharmacokinetic Aspects of Digoxin-Specific Fab Therapy in the Management of Digitalis Toxicity,&quot; <i>Clin Pharmacokinet</i>, 1995, 28(6):483-93.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-pediatric-drug-information/abstract-text/7656506/pubmed\" target=\"_blank\" id=\"7656506\">7656506</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 13231 Version 81.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F160237\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F160238\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1057851\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F12669226\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1057846\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F160219\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F160203\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1057855\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F160232\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1057854\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F160260\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F160225\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F160207\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299196\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F6219862\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F160215\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F160227\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1057850\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F160206\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F160224\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323111\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F160228\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/13231|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=digoxin-immune-fab-drug-information\" class=\"drug drug_general\">Digoxin immune Fab: Drug information</a></li><li><a href=\"topic.htm?path=digoxin-immune-fab-patient-drug-information\" class=\"drug drug_patient\">Digoxin immune Fab: Patient drug information</a></li></ul></div></div>","javascript":null}